Predictors and Outcomes of Subclinical Inflammation in Pediatric Patients with Familial Mediterranean Fever: A Retrospective Cohort Study from a Single Center - Scorecard - MDSpire
Advertisement
Predictors and Outcomes of Subclinical Inflammation in Pediatric Patients with Familial Mediterranean Fever: A Retrospective Cohort Study from a Single Center
Clinical Scorecard: Predictors and Outcomes of Subclinical Inflammation in Pediatric Patients with Familial Mediterranean Fever: A Retrospective Cohort Study from a Single Center
At a Glance
Category
Detail
Condition
Familial Mediterranean Fever (FMF)
Key Mechanisms
Genetic mutations in the MEFV gene leading to dysregulation of inflammation and apoptosis.
Target Population
Pediatric patients diagnosed with FMF, particularly those of Mediterranean descent.
Care Setting
Pediatric rheumatology outpatient clinic.
Key Highlights
Subclinical inflammation is common in FMF, affecting long-term outcomes.
Colchicine is the primary treatment, but 5-10% of patients may be resistant.
IL-1β–targeted therapies show promise for colchicine-resistant patients.
Genotype-phenotype correlations are significant in FMF pathogenesis.
Subclinical inflammation can lead to complications like anemia and growth retardation.
Guideline-Based Recommendations
Diagnosis
Diagnosis based on Yalçınkaya–Ozen criteria and genetic testing for MEFV mutations.
Management
Colchicine is the first-line treatment; consider IL-1β inhibitors for resistant cases.
Monitoring & Follow-up
Regular assessment of inflammatory markers (CRP, ESR) during attack-free periods.
Risks
Increased risk of complications such as AA amyloidosis and growth issues in children.
Patient & Prescribing Data
Pediatric patients under 18 years with FMF.
Colchicine is effective for most, but alternative therapies are needed for resistant cases.
Clinical Best Practices
Systematic follow-up assessments for attacks and infections.
Use of the International Severity Scoring System for FMF to evaluate disease severity.
Personalized treatment strategies based on genetic and clinical factors.
So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.
